» Articles » PMID: 18212089

High-throughput Biochemical Analysis of in Vivo Location Data Reveals Novel Distinct Classes of POU5F1(Oct4)/DNA Complexes

Overview
Journal Genome Res
Specialty Genetics
Date 2008 Jan 24
PMID 18212089
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The transcription factor POU5F1 is a key regulator of embryonic stem (ES) cell pluripotency and a known oncoprotein. We have developed a novel high-throughput binding assay called MEGAshift (microarray evaluation of genomic aptamers by shift) that we use to pinpoint the exact location, affinity, and stoichiometry of the DNA-protein complexes identified by chromatin immunoprecipitation studies. We consider all genomic regions identified as POU5F1-ChIP-enriched in both human and mouse. Compared with regions that are ChIP-enriched in a single species, we find these regions more likely to be near actively transcribed genes in ES cells. We resynthesize these genomic regions as a pool of tiled 35-mers. This oligonucleotide pool is then assayed for binding to recombinant POU5F1 by gel shift. The degree of binding for each oligonucleotide is accurately measured on a custom oligonucleotide microarray. We explore the relationship between experimentally determined and computationally predicted binding strengths, find many novel functional combinations of POU5F1 half sites, and demonstrate efficient motif discovery by incorporating binding information into a motif finding algorithm. In addition to further refining location studies for transcription factors, this method holds promise for the high-throughput screening of promoters, SNP regions, and epigenetic modifications for factor binding.

Citing Articles

RSAT matrix-clustering: dynamic exploration and redundancy reduction of transcription factor binding motif collections.

Castro-Mondragon J, Jaeger S, Thieffry D, Thomas-Chollier M, van Helden J Nucleic Acids Res. 2017; 45(13):e119.

PMID: 28591841 PMC: 5737723. DOI: 10.1093/nar/gkx314.


Enforcement of developmental lineage specificity by transcription factor Oct1.

Shen Z, Kang J, Shakya A, Tabaka M, Jarboe E, Regev A Elife. 2017; 6.

PMID: 28537559 PMC: 5466424. DOI: 10.7554/eLife.20937.


Dry and wet approaches for genome-wide functional annotation of conventional and unconventional transcriptional activators.

Levati E, Sartini S, Ottonello S, Montanini B Comput Struct Biotechnol J. 2016; 14:262-70.

PMID: 27453771 PMC: 4941109. DOI: 10.1016/j.csbj.2016.06.004.


The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Vazquez-Arreguin K, Tantin D Biochim Biophys Acta. 2016; 1859(6):792-804.

PMID: 26877236 PMC: 4880489. DOI: 10.1016/j.bbagrm.2016.02.007.


Using protein-binding microarrays to study transcription factor specificity: homologs, isoforms and complexes.

Andrilenas K, Penvose A, Siggers T Brief Funct Genomics. 2014; 14(1):17-29.

PMID: 25431149 PMC: 4366590. DOI: 10.1093/bfgp/elu046.


References
1.
Orlando V, Paro R . Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell. 1993; 75(6):1187-98. DOI: 10.1016/0092-8674(93)90328-n. View

2.
Botquin V, Hess H, Fuhrmann G, Anastassiadis C, Gross M, Vriend G . New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 1998; 12(13):2073-90. PMC: 316977. DOI: 10.1101/gad.12.13.2073. View

3.
Remenyi A, Lins K, Nissen L, Reinbold R, Scholer H, Wilmanns M . Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev. 2003; 17(16):2048-59. PMC: 196258. DOI: 10.1101/gad.269303. View

4.
Nishimoto M, Miyagi S, Katayanagi T, Tomioka M, Muramatsu M, Okuda A . The embryonic Octamer factor 3/4 displays distinct DNA binding specificity from those of other Octamer factors. Biochem Biophys Res Commun. 2003; 302(3):581-6. DOI: 10.1016/s0006-291x(03)00218-3. View

5.
Atlasi Y, Mowla S, Ziaee S, Bahrami A . OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer. 2007; 120(7):1598-602. DOI: 10.1002/ijc.22508. View